Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Stryker management to meet with BTIG » 05:55
03/08/23
03/08
05:55
03/08/23
05:55
SYK

Stryker

$264.68 /

-2.805 (-1.05%)

BTIG Medical Technology…

BTIG Medical Technology Analyst Zimmerman holds a reception and a discussion in conjunction with the American Academy of Orthopaedic Surgeons Conference 2023 in Las Vegas on March 8.

ShowHide Related Items >><<
SYK Stryker
$264.68 /

-2.805 (-1.05%)

SYK Stryker
$264.68 /

-2.805 (-1.05%)

02/21/23 Argus
Stryker price target raised to $285 from $270 at Argus
02/02/23 Barclays
Stryker price target raised to $283 from $265 at Barclays
02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
SYK Stryker
$264.68 /

-2.805 (-1.05%)

SYK Stryker
$264.68 /

-2.805 (-1.05%)

SYK Stryker
$264.68 /

-2.805 (-1.05%)

Conference/Events
Stryker management to meet with BTIG » 09:46
03/07/23
03/07
09:46
03/07/23
09:46
SYK

Stryker

$269.17 /

+1.685 (+0.63%)

BTIG Medical Technology…

BTIG Medical Technology Analyst Zimmerman holds a reception and a discussion in conjunction with the American Academy of Orthopaedic Surgeons Conference 2023 in Las Vegas on March 8.

ShowHide Related Items >><<
SYK Stryker
$269.17 /

+1.685 (+0.63%)

SYK Stryker
$269.17 /

+1.685 (+0.63%)

02/21/23 Argus
Stryker price target raised to $285 from $270 at Argus
02/02/23 Barclays
Stryker price target raised to $283 from $265 at Barclays
02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
SYK Stryker
$269.17 /

+1.685 (+0.63%)

SYK Stryker
$269.17 /

+1.685 (+0.63%)

SYK Stryker
$269.17 /

+1.685 (+0.63%)

Over a month ago
Recommendations
Stryker price target raised to $285 from $270 at Argus » 08:11
02/21/23
02/21
08:11
02/21/23
08:11
SYK

Stryker

$263.08 /

-0.3 (-0.11%)

Argus raised the…

Argus raised the firm's price target on Stryker to $285 from $270 and keeps a Buy rating on the shares. The analyst cites the company's Q4 earnings beat while noting that Stryker enters 2023 with a robust new order book in its MedSurg segment and higher procedural volume in its Orthopedics & Spine segment. The stock's valuation of 23-times expected forward earnings is above the average multiple of 21-times in the firm's coverage universe of medical device stocks, but Stryker's growth opportunities and success in integrating acquisitions support this premium valuation, the firm tells investors in a research note.

ShowHide Related Items >><<
SYK Stryker
$263.08 /

-0.3 (-0.11%)

SYK Stryker
$263.08 /

-0.3 (-0.11%)

02/02/23 Barclays
Stryker price target raised to $283 from $265 at Barclays
02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
02/01/23 Canaccord
Stryker price target raised to $250 from $220 at Canaccord
SYK Stryker
$263.08 /

-0.3 (-0.11%)

SYK Stryker
$263.08 /

-0.3 (-0.11%)

SYK Stryker
$263.08 /

-0.3 (-0.11%)

Hot Stocks
Stryker's Q Guidance System for cranial applications receives FDA clearance » 09:33
02/17/23
02/17
09:33
02/17/23
09:33
SYK

Stryker

$263.26 /

-1.94 (-0.73%)

Stryker announced that…

Stryker announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the U.S. Food and Drug Administration. The Q Guidance System is an image-based planning and intraoperative guidance system designed to support cranial surgeries, the firm says. Recently launched in September 2022, the Q Guidance System for spinal applications is currently available on the market. "The FDA clearance of Stryker's Q Guidance System with Cranial Guidance Software is a key milestone, which will help lead the transformation of cranial navigation and surgery," said Robbie Robinson, president of Stryker's Spine division. "Our robust pipeline of iterative launches reinforces our commitment to making industry-leading investments focused on providing advanced navigation products and differentiated technologies that our surgeon customers have come to expect."

ShowHide Related Items >><<
SYK Stryker
$263.26 /

-1.94 (-0.73%)

SYK Stryker
$263.26 /

-1.94 (-0.73%)

02/02/23 Barclays
Stryker price target raised to $283 from $265 at Barclays
02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
02/01/23 Canaccord
Stryker price target raised to $250 from $220 at Canaccord
SYK Stryker
$263.26 /

-1.94 (-0.73%)

SYK Stryker
$263.26 /

-1.94 (-0.73%)

SYK Stryker
$263.26 /

-1.94 (-0.73%)

Hot Stocks
Stryker exec Menon sells 2,161 common shares » 17:37
02/13/23
02/13
17:37
02/13/23
17:37
SYK

Stryker

$266.90 /

+2.58 (+0.98%)

In a regulatory filing,…

In a regulatory filing, Stryker group president Viju Menon disclosed the sale of 2,161 common shares of the company on February 9 at a price of $264.3065 per share.

ShowHide Related Items >><<
SYK Stryker
$266.90 /

+2.58 (+0.98%)

SYK Stryker
$266.90 /

+2.58 (+0.98%)

02/02/23 Barclays
Stryker price target raised to $283 from $265 at Barclays
02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
02/01/23 Canaccord
Stryker price target raised to $250 from $220 at Canaccord
SYK Stryker
$266.90 /

+2.58 (+0.98%)

SYK Stryker
$266.90 /

+2.58 (+0.98%)

SYK Stryker
$266.90 /

+2.58 (+0.98%)

Hot Stocks
Stryker CFO Boehnlein sells $6.8M in common stock » 18:26
02/06/23
02/06
18:26
02/06/23
18:26
SYK

Stryker

$271.36 /

-11.71 (-4.14%)

In a regulatory filing,…

In a regulatory filing, Stryker disclosed that its CFO Glenn Boehnlein had sold 24.4K shares of its common stock during February 2nd in a total transaction size of $6.8M.

ShowHide Related Items >><<
SYK Stryker
$271.36 /

-11.71 (-4.14%)

SYK Stryker
$271.36 /

-11.71 (-4.14%)

02/02/23 Barclays
Stryker price target raised to $283 from $265 at Barclays
02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
02/01/23 Canaccord
Stryker price target raised to $250 from $220 at Canaccord
SYK Stryker
$271.36 /

-11.71 (-4.14%)

SYK Stryker
$271.36 /

-11.71 (-4.14%)

SYK Stryker
$271.36 /

-11.71 (-4.14%)

Recommendations
Stryker price target raised to $283 from $265 at Barclays » 06:37
02/02/23
02/02
06:37
02/02/23
06:37
SYK

Stryker

$278.90 /

+24.97 (+9.83%)

Barclays analyst Matt…

Barclays analyst Matt Miksic raised the firm's price target on Stryker to $283 from $265 and keeps an Overweight rating on the shares. The company delivered "robust" Q4 organic growth, earnings guidance above estimates and tempered organic sales guidance, the analyst tells investors in a research note. The firm believes Stryker's "strong momentum" and new product launches in robotic surgery, ortho implants and capital equipment position the company for potential upward revisions throughout 2023.

ShowHide Related Items >><<
SYK Stryker
$278.90 /

+24.97 (+9.83%)

SYK Stryker
$278.90 /

+24.97 (+9.83%)

02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
02/01/23 Canaccord
Stryker price target raised to $250 from $220 at Canaccord
02/01/23 Truist
Stryker price target raised to $275 from $257 at Truist
SYK Stryker
$278.90 /

+24.97 (+9.83%)

SYK Stryker
$278.90 /

+24.97 (+9.83%)

SYK Stryker
$278.90 /

+24.97 (+9.83%)

Options
Early notable gainers among liquid option names on February 1st » 09:55
02/01/23
02/01
09:55
02/01/23
09:55
SYK

Stryker

$273.00 /

+19.07 (+7.51%)

, AMD

AMD

$79.55 /

+4.36 (+5.80%)

, ODFL

Old Dominion

$356.00 /

+22.715 (+6.82%)

, TMO

Thermo Fisher

$583.00 /

+12.86 (+2.26%)

, EW

Edwards Lifesciences

$79.50 /

+2.81 (+3.66%)

Notable gainers among…

Notable gainers among liquid option names this morning include Stryker (SYK) $274.57 +20.76, Advanced Micro (AMD) $79.61 +4.46, Old Dominion (ODFL) $352.23 +18.99, Thermo Fisher (TMO) $595.59 +25.26, and Edwards Lifesciences (EW) $80.09 +3.39.

ShowHide Related Items >><<
TMO Thermo Fisher
$583.00 /

+12.86 (+2.26%)

SYK Stryker
$273.00 /

+19.07 (+7.51%)

ODFL Old Dominion
$356.00 /

+22.715 (+6.82%)

EW Edwards Lifesciences
$79.50 /

+2.81 (+3.66%)

AMD AMD
$79.55 /

+4.36 (+5.80%)

SYK Stryker
$273.00 /

+19.07 (+7.51%)

02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
02/01/23 Canaccord
Stryker price target raised to $250 from $220 at Canaccord
02/01/23 Truist
Stryker price target raised to $275 from $257 at Truist
AMD AMD
$79.55 /

+4.36 (+5.80%)

02/01/23 Craig-Hallum
Craig-Hallum downgrades AMD to Hold on slowing growth
02/01/23 Northland
AMD guidance 'isn't great,' but 'not a disaster,' says Northland
02/01/23 Craig-Hallum
AMD downgraded to Hold from Buy at Craig-Hallum
02/01/23 Morgan Stanley
AMD's softer outlook 'still could be a relief' after Intel, says Morgan Stanley
ODFL Old Dominion
$356.00 /

+22.715 (+6.82%)

01/30/23 Credit Suisse
Old Dominion downgraded to Underperform from Neutral at Credit Suisse
01/20/23 Raymond James
Old Dominion price target raised to $335 from $300 at Raymond James
01/17/23 BofA
Schneider, Werner upgraded to Buy, XPO Logistics downgraded at BofA
01/17/23 BofA
Old Dominion upgraded to Neutral from Underperform at BofA
TMO Thermo Fisher
$583.00 /

+12.86 (+2.26%)

01/24/23 Barclays
Thermo Fisher price target raised to $630 from $570 at Barclays
01/03/23 Wells Fargo
Thermo Fisher price target lowered to $505 from $525 at Wells Fargo
12/13/22 Deutsche Bank
Thermo Fisher initiated with a Buy at Deutsche Bank
12/06/22 RBC Capital
Thermo Fisher initiated with an Outperform at RBC Capital
EW Edwards Lifesciences
$79.50 /

+2.81 (+3.66%)

02/01/23 Canaccord
Edwards Lifesciences price target raised to $76 from $68 at Canaccord
01/31/23 Bernstein
Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
01/30/23 Piper Sandler
Edwards Lifesciences downgraded to Neutral from Overweight at Piper Sandler
12/12/22 Canaccord
Edwards Lifesciences price target lowered to $73 from $78 at Canaccord
TMO Thermo Fisher
$583.00 /

+12.86 (+2.26%)

SYK Stryker
$273.00 /

+19.07 (+7.51%)

ODFL Old Dominion
$356.00 /

+22.715 (+6.82%)

EW Edwards Lifesciences
$79.50 /

+2.81 (+3.66%)

AMD AMD
$79.55 /

+4.36 (+5.80%)

TMO Thermo Fisher
$583.00 /

+12.86 (+2.26%)

ODFL Old Dominion
$356.00 /

+22.715 (+6.82%)

AMD AMD
$79.55 /

+4.36 (+5.80%)

TMO Thermo Fisher
$583.00 /

+12.86 (+2.26%)

SYK Stryker
$273.00 /

+19.07 (+7.51%)

EW Edwards Lifesciences
$79.50 /

+2.81 (+3.66%)

AMD AMD
$79.55 /

+4.36 (+5.80%)

TMO Thermo Fisher
$583.00 /

+12.86 (+2.26%)

SYK Stryker
$273.00 /

+19.07 (+7.51%)

ODFL Old Dominion
$356.00 /

+22.715 (+6.82%)

EW Edwards Lifesciences
$79.50 /

+2.81 (+3.66%)

AMD AMD
$79.55 /

+4.36 (+5.80%)

On The Fly
Fly Intel: Pre-market Movers » 08:53
02/01/23
02/01
08:53
02/01/23
08:53
TMO

Thermo Fisher

$570.40 /

+6.335 (+1.12%)

, MO

Altria Group

$45.05 /

+0.56 (+1.26%)

, DT

Dynatrace

$38.38 /

+0.345 (+0.91%)

, PTON

Peloton

$12.92 /

+0.405 (+3.24%)

, EAT

Brinker

$39.45 /

+0.85 (+2.20%)

, SYK

Stryker

$253.76 /

+4.245 (+1.70%)

, AMD

AMD

$75.19 /

+2.76 (+3.81%)

, TMUS

T-Mobile

$149.39 /

+2.47 (+1.68%)

, SNAP

Snap

$11.56 /

+0.43 (+3.86%)

, EA

Electronic Arts

$128.56 /

-0.47 (-0.36%)

Check out this morning's…

ShowHide Related Items >><<
TMUS T-Mobile
$149.39 /

+2.47 (+1.68%)

TMO Thermo Fisher
$570.40 /

+6.335 (+1.12%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

PTON Peloton
$12.92 /

+0.405 (+3.24%)

MO Altria Group
$45.05 /

+0.56 (+1.26%)

EAT Brinker
$39.45 /

+0.85 (+2.20%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

DT Dynatrace
$38.38 /

+0.345 (+0.91%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

TMO Thermo Fisher
$570.40 /

+6.335 (+1.12%)

01/24/23 Barclays
Thermo Fisher price target raised to $630 from $570 at Barclays
01/03/23 Wells Fargo
Thermo Fisher price target lowered to $505 from $525 at Wells Fargo
12/13/22 Deutsche Bank
Thermo Fisher initiated with a Buy at Deutsche Bank
12/06/22 RBC Capital
Thermo Fisher initiated with an Outperform at RBC Capital
MO Altria Group
$45.05 /

+0.56 (+1.26%)

11/10/22 UBS
UBS downgrades Altria to Sell on consumer trade down risk
11/10/22 UBS
Altria Group downgraded to Sell from Neutral at UBS
11/02/22 Morgan Stanley
Philip Morris price target raised to $109 from $102 at Morgan Stanley
10/28/22 Stifel
Altria JV news trumps 'rare' EPS miss, says Stifel
DT Dynatrace
$38.38 /

+0.345 (+0.91%)

01/10/23 Barclays
Dynatrace downgraded to Equal Weight from Overweight at Barclays
01/09/23 Truist
Dynatrace price target lowered to $45 from $50 at Truist
01/03/23 Wells Fargo
Dynatrace price target raised to $50 from $45 at Wells Fargo
12/15/22 Wedbush
Wedbush initiates Dynatrace with a Neutral and $35 price target
PTON Peloton
$12.92 /

+0.405 (+3.24%)

01/30/23 Citi
Peloton promotions drove improved traffic trends, says Citi
01/24/23 MKM Partners
MKM Partners positive on Peloton heading into earnings
01/24/23 Baird
Peloton downgraded to Neutral from Outperform at Baird
11/21/22 TD Cowen
Peloton downgraded to Market Perform from Outperform at Cowen
EAT Brinker
$39.45 /

+0.85 (+2.20%)

01/24/23 Deutsche Bank
Brinker price target raised to $38 from $34 at Deutsche Bank
01/05/23 Barclays
Brinker price target lowered to $30 from $31 at Barclays
12/21/22 Jefferies
Brinker downgraded to Hold from Buy at Jefferies
12/12/22 Goldman Sachs
Brinker downgraded to Sell from Neutral at Goldman Sachs
SYK Stryker
$253.76 /

+4.245 (+1.70%)

02/01/23 Loop Capital
Stryker price target raised to $290 from $245 at Loop Capital
02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
02/01/23 Canaccord
Stryker price target raised to $250 from $220 at Canaccord
02/01/23 Truist
Stryker price target raised to $275 from $257 at Truist
AMD AMD
$75.19 /

+2.76 (+3.81%)

02/01/23 Craig-Hallum
Craig-Hallum downgrades AMD to Hold on slowing growth
02/01/23 Northland
AMD guidance 'isn't great,' but 'not a disaster,' says Northland
02/01/23 Craig-Hallum
AMD downgraded to Hold from Buy at Craig-Hallum
02/01/23 Morgan Stanley
AMD's softer outlook 'still could be a relief' after Intel, says Morgan Stanley
TMUS T-Mobile
$149.39 /

+2.47 (+1.68%)

01/17/23 KeyBanc
Cogent price target raised to $71 from $64 at KeyBanc
01/13/23 Truist
American Tower price target lowered to $275 from $325 at Truist
01/05/23 JPMorgan
T-Mobile remains a top pick after preannouncement at JPMorgan
01/03/23 Wolfe Research
T-Mobile downgraded to Peer Perform from Outperform at Wolfe Research
SNAP Snap
$11.56 /

+0.43 (+3.86%)

02/01/23 Rosenblatt
Snap price target raised to $10 from $8 at Rosenblatt
02/01/23 Canaccord
Snap price target lowered to $11 from $12 at Canaccord
02/01/23 Benchmark
Benchmark downgrades 'too far behind' Snap to Hold after earnings
02/01/23 Susquehanna
Snap price target raised to $10 from $8 at Susquehanna
EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

02/01/23 Wells Fargo
Electronic Arts price target lowered to $120 from $150 at Wells Fargo
02/01/23 Roth MKM
Electronic Arts price target lowered to $112 from $131 at Roth Capital
02/01/23 Wedbush
Electronic Arts price target lowered to $139 from $164 at Wedbush
02/01/23 TD Cowen
Electronic Arts price target lowered to $136 from $158 at Cowen
TMUS T-Mobile
$149.39 /

+2.47 (+1.68%)

TMO Thermo Fisher
$570.40 /

+6.335 (+1.12%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

PTON Peloton
$12.92 /

+0.405 (+3.24%)

MO Altria Group
$45.05 /

+0.56 (+1.26%)

EAT Brinker
$39.45 /

+0.85 (+2.20%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

DT Dynatrace
$38.38 /

+0.345 (+0.91%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

TMUS T-Mobile
$149.39 /

+2.47 (+1.68%)

TMO Thermo Fisher
$570.40 /

+6.335 (+1.12%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

PTON Peloton
$12.92 /

+0.405 (+3.24%)

MO Altria Group
$45.05 /

+0.56 (+1.26%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

TMUS T-Mobile
$149.39 /

+2.47 (+1.68%)

TMO Thermo Fisher
$570.40 /

+6.335 (+1.12%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

PTON Peloton
$12.92 /

+0.405 (+3.24%)

MO Altria Group
$45.05 /

+0.56 (+1.26%)

EAT Brinker
$39.45 /

+0.85 (+2.20%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

DT Dynatrace
$38.38 /

+0.345 (+0.91%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

TMUS T-Mobile
$149.39 /

+2.47 (+1.68%)

TMO Thermo Fisher
$570.40 /

+6.335 (+1.12%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SNAP Snap
$11.56 /

+0.43 (+3.86%)

PTON Peloton
$12.92 /

+0.405 (+3.24%)

MO Altria Group
$45.05 /

+0.56 (+1.26%)

EA Electronic Arts
$128.56 /

-0.47 (-0.36%)

AMD AMD
$75.19 /

+2.76 (+3.81%)

Recommendations
Stryker price target raised to $290 from $245 at Loop Capital » 08:22
02/01/23
02/01
08:22
02/01/23
08:22
SYK

Stryker

$253.76 /

+4.245 (+1.70%)

Loop Capital analyst…

Loop Capital analyst Jason Wittes raised the firm's price target on Stryker to $290 from $245 and keeps a Buy rating on the shares. The company's Q4 earnings and revenue topped expectations amid robust topline growth, though this was partially offset by negative currency headwinds and high inflationary pressure, the analyst tells investors in a research note. The firm "sees only upside" in the stock, though macro concerns do remain, Loop Capital added.

ShowHide Related Items >><<
SYK Stryker
$253.76 /

+4.245 (+1.70%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

02/01/23 BTIG
Stryker price target raised to $281 from $268 at BTIG
02/01/23 Canaccord
Stryker price target raised to $250 from $220 at Canaccord
02/01/23 Truist
Stryker price target raised to $275 from $257 at Truist
02/01/23 RBC Capital
Stryker price target raised to $288 from $284 at RBC Capital
SYK Stryker
$253.76 /

+4.245 (+1.70%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

SYK Stryker
$253.76 /

+4.245 (+1.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.